FOXF1

forkhead box F1

Explore in graph →CI-GENE-00002150HGNC:3809 ENSG00000103241 NCBI 2294 CIViC Approved

Curated evidence

Clinical evidence (1)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
FOXF1 Overexpression1
Bevacizumab	Malignant Colorectal NeoplasmCURATED_BROADER	Predictive	D	Supports Resistance	4	submitted	EID9233 As high expression of FOXF1 was associated with higher progression, poorer survival, and increased microvessel density in colorectal cancer (CRC) patients (p < 0.001), the in vitro effects of bevacizu… (full text at CIViC) PMID 30253191 · Wang et al., 2018 · Open in CIViC	civic

Cohorts

Alteration frequency by cohort (5)

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

cbioportalObserved5 cohort rows · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Non-Small Cell Lung Cancer (MSK, 2026) alk_msk_2026	Lung Non-Small Cell Carcinoma	Ssm	3	46	6.5%	99

Literature

Linked publications (0)

Data not yet available

No publication linked to this gene yet.